论文部分内容阅读
最近,葛兰素公司在中国推出一种全新的长效β_2-受体激动剂——沙美特罗羟基萘酸盐(Salmeterol Xinafoate),它的作用特点在于长效,每天只需用药两次(早、晚各一次)。
Recently, GlaxoSmithKline launched a new long-acting β 2 -agonist Salmeterol Xinafoate in China, which is characterized by its long-acting effect and its need for twice-daily administration only Morning and evening each time).